Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024

Biotech stocks are always interesting from a trading perspective. With dozens of companies in the clinicalstage, positive news from trials can be a big catalyst for a scintillating rally. Biotech stocks were however subdued in a post-pandemic world with focus shifting to other sectors. This has translated into undervalued in several interesting biotech stocks under $10. An important point to note is that clinical-stage biotech stocks are participants in a meme stock rally. With multiple rate cuts likely in ...